Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 13:14:10.
doi: 10.1186/s11556-017-0179-1. eCollection 2017.

Physical activity does not alter prolactin levels in post-menopausal women: results from a dose-response randomized controlled trial

Affiliations

Physical activity does not alter prolactin levels in post-menopausal women: results from a dose-response randomized controlled trial

Darren R Brenner et al. Eur Rev Aging Phys Act. .

Abstract

Background: Increased circulating levels of prolactin have been associated with increased risk of both in situ and invasive breast cancer. We investigated whether or not physical activity had a dose-response effect in lowering plasma levels of prolactin in postmenopausal women.

Methods: Four hundred previously inactive but healthy postmenopausal women aged 50-74 years of age were randomized to 150 or 300 min per week of aerobic physical activity in a year-long intervention. Prolactin was measured from fasting samples with a custom-plex multiplex assay.

Results: A high compared to moderate volume of physical activity did not reduce plasma prolactin levels in intention-to-treat (Treatment Effect Ratio (TER) 1.00, 95% Confidence Interval (CI) 0.95 - 1.06) or per-protocol analyses (TER 1.02, 95% CI 0.93 - 1.13).

Conclusions: It is unlikely that changes in prolactin levels mediate the reduced risk of breast cancer development in post-menopausal women associated with increased levels of physical activity.

Trial registration: clinicaltrials.gov identifier: NCT01435005.

Keywords: Breast Cancer; Physical Activity; Prolactin; Randomized Controlled Trial.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by the Health Research Ethics Board of Alberta and all participants consented to participate.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer. 2010;46(14):2593–2604. doi: 10.1016/j.ejca.2010.07.028. - DOI - PubMed
    1. Wang M, Wu X, Chai F, Zhang Y, Jiang J. Plasma prolactin and breast cancer risk: a meta- analysis. Sci Rep. 2016;6:25998. doi: 10.1038/srep25998. - DOI - PMC - PubMed
    1. Tworoger SS, Sorensen B, Chubak J, et al. Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2007;16(5):895–899. doi: 10.1158/1055-9965.EPI-06-0701. - DOI - PubMed
    1. Reding KW, Lampe JW, Wang CY, et al. A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations. Cancer Epidemiol. 2011;35(6):569–573. doi: 10.1016/j.canep.2011.01.006. - DOI - PMC - PubMed
    1. Friedenreich CM, MacLaughlin S, Neilson HK, et al. Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA) BMC Cancer. 2014;14:919. doi: 10.1186/1471-2407-14-919. - DOI - PMC - PubMed

Associated data

LinkOut - more resources